Clinical Trials Logo

Supraspinatus Tendinopathy clinical trials

View clinical trials related to Supraspinatus Tendinopathy.

Filter by:
  • None
  • Page 1

NCT ID: NCT03942640 Recruiting - Clinical trials for Supraspinatus Tendinopathy

Perineural Injection and Supraspinatus Tendenopathy

Start date: June 1, 2019
Phase: N/A
Study type: Interventional

Atotal of 150 consecutive patients with chronic supraspinatous tendinopathy were invited to participate in the study .patients were recruited from the out patient clinic of rheumatology and rehabilitation department,Mansoura university hospital a. perineural injection therapy group (subcutaneous prolotherapy) This group included 30 patients aged from 18 to 60 years Deep prolotherapy injection group The injection fluid contain 1 ml of 255 glucose and 1ml of lidocaine. The pathological area of the supraspinatous tendon was identified and graded using ultrasound pathology rating scale guided by ultrasonography (Simens Acuson p300 machine) Proper preparation with antiseptic solution of skin overlying the point of injection .

NCT ID: NCT02196948 Completed - Clinical trials for Supraspinatus Tendinopathy

Electrolysis Percutaneous Therapeutic (EPTE) for Supraspinatus Tendinopathy

Start date: July 2014
Phase: N/A
Study type: Interventional

Therapeutic management of supraspinatus tendinopathy is conflicting. There is evidence that eccentric exercise protocols can be effective for this condition. The inclusion of other therapeutic modalities could help to the management of these patients. A new therapeutic approach, called Electrolysis Percutaneous Therapeutic (EPTE) has been clinically developed. The objective of this randomized clinical trial is to determine the effectiveness of the inclusion of EPTE into a eccentric exercise protocol for the management of patients with unilateral supraspinatus tendinopathy